Ascelia Pharma AB Financial Overview
Ascelia Pharma AB's market cap is currently €390.59M. The company's EPS TTM is kr-0.133; its P/E ratio is -2.68; Ascelia Pharma AB is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
